Fig. 6

The relationship between TMB and ERS-related lncRNA signature. (A-B) The oncoplots show the top 15 gene with the highest mutation rate in the high-risk group (A) and low-risk group (B); (C)TMB differences between high-risk and low-risk groups; (D) Relationship between TMB and risk scores; (E) Kaplan–Meier survival analysis of LSCC patients between the High-TMB and Low-TMB patients; (F) Kaplan–Meier survival curves of LSCC patients across High-TMB + high risk, High-TMB + low risk, Low-TMB + high risk, and Low-TMB + low risk. TMB, tumor mutational burden.